A phase 3 study of the effect of denosumab therapy on bone mineral density in women receiving aromatase inhibitors for non metastatic breast cancer

被引：0
|
作者：
Ellis, G.
Bone, H. G.
Chlebowski, R.
Paul, D.
Spadafora, S.
Smith, J.
Fan, M.
Jun, S.
机构：
[1] Seattle Canc Care Alliance, Seattle, WA USA
[2] Michigan Bone & Mineral Clin, Detroit, MI USA
[3] UCLA Med Ctr, Torrance, CA USA
[4] Rocky Mt Canc Ctr, Denver, CO USA
[5] Algoma Reg Canc Program, Saulte Ste Marie, ON, Canada
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2008年 / 109卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：585 / 586
页数：2
相关论文
共 50 条
  • [21] Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
    Catherine Van Poznak
    Breast Cancer Research, 12
  • [22] Effect of Aromatase Inhibitors on Bone Mineral Density in a Japanese Breast Cancer Population
    Akiyoshi, Takeshi
    Shimomura, Yuka
    Masuda, Shinichi
    Okamoto, Yasushi
    Hiura, Sumiko
    Kato, Hiroyoshi
    Asayama, Toru
    Ohtani, Hisakazu
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (05) : 446 - 450
  • [23] A 24-month subgroup analysis of the effect of denosumab on bone mineral density in women with breast cancer undergoing aromatase inhibitor therapy.
    Ellis, G. K.
    Bone, H. G.
    Chlebowski, R.
    Paul, D.
    Spadafora, S.
    Fan, M.
    Kim, D.
    CANCER RESEARCH, 2009, 69 (02) : 188S - 189S
  • [24] Subgroup analysis of a randomized, phase III study of the effect of denosumab in women with nonmetastatic breast cancer receiving aromatase inhibitor (AI) therapy
    Ellis, G. K.
    Bone, H. G.
    Chlebowski, R. T.
    Paul, D.
    Spadafora, S.
    Smith, J.
    Fan, M.
    Jun, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Efficacy of denosumab on bone mineral density in postmenopausal women with low bone mass and patients with breast cancer on adjuvant aromatase inhibitor (AI) therapy
    Bone, H. G.
    Ellis, G.
    Yuen, C. K.
    Kendler, D. L.
    Fan, M.
    Wang, H.
    Kim, D.
    Liu, Y.
    Dansey, R.
    Martin, J. San
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S38 - S38
  • [26] EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY AND TRABECULAR BONE MICROARCHITECTURE IN PATIENTS WITH BREAST CANCER
    Tsagareli, M.
    Giorgadze, E.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S189 - S189
  • [27] Effect of denosumab on bone mineral density (T-score classification of-1.0 to-2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.
    Nakatsukasa, Katsuhiko
    Matsuda, Takayuki
    Taguchi, Tetsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Bone Mineral Density Screening Among Women with a History of Breast Cancer Treated with Aromatase Inhibitors
    Spangler, Leslie
    Yu, Onchee
    Loggers, Elizabeth
    Boudreau, Denise M.
    JOURNAL OF WOMENS HEALTH, 2013, 22 (02) : 132 - 140
  • [29] IMPACT OF CHEMOTHERAPY ON BONE MINERAL DENSITY IN POSTMENOPATHIC WOMEN WITH BREAST CANCER IN TREATMENT WITH AROMATASE INHIBITORS
    Loarce-Martos, J.
    Sifuentes Giraldo, W. A.
    Maldonado Romero, L. V.
    Ahijon Lana, M.
    Velazquez Arce, C.
    Martinez Janez, N.
    Vazquez Diaz, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 698 - 698
  • [30] Bone Health in Postmenopausal Women with Breast Cancer Receiving Aromatase Inhibitors
    Zikan, Vit
    Zimovjanova, Martina
    Petruzelka, Lubos
    Pribylova, Jana
    Cabinakova, Michaela
    Raskova, Maria
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
12345